United States · FDA National Drug Code directory
CYCLOBENZAPRINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85509-1014_3a90172c-fe2c-0eee-e063-6294a90a6018
- Product NDC
- 85509-1014
- Form
- TABLET, FILM COATED
- Composition / generic term
- cyclobenzaprine hydrochloride
- Labeler
- PHOENIX RX LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250320
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (85509-1014-3) · 85509-1014-3
- 60 TABLET, FILM COATED in 1 BOTTLE (85509-1014-6) · 85509-1014-6
- 90 TABLET, FILM COATED in 1 BOTTLE (85509-1014-9) · 85509-1014-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →